James Izanec

559 total citations
23 papers, 128 citations indexed

About

James Izanec is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, James Izanec has authored 23 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in James Izanec's work include Inflammatory Bowel Disease (20 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (7 papers). James Izanec is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (7 papers). James Izanec collaborates with scholars based in United States, United Kingdom and Italy. James Izanec's co-authors include Deborah Nagle, Silvio Danese, Robert S. Fisher, David Friedel, Henry P. Parkman, Zhijie Ding, Peter Axelrod, Edward V. Loftus, Remo Panaccione and Peter M. Irving and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

James Izanec

21 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Izanec United States 7 90 67 59 26 21 23 128
Anders Forss Sweden 8 141 1.6× 138 2.1× 78 1.3× 28 1.1× 21 1.0× 33 196
Laurent Peyrin-Biroulet France 7 102 1.1× 66 1.0× 41 0.7× 15 0.6× 31 1.5× 43 151
Cyrielle Gilletta France 7 103 1.1× 75 1.1× 46 0.8× 12 0.5× 28 1.3× 22 140
Daniel Hervías Spain 6 83 0.9× 63 0.9× 65 1.1× 8 0.3× 15 0.7× 13 139
Luca Ferraris Italy 5 163 1.8× 128 1.9× 74 1.3× 34 1.3× 32 1.5× 10 213
Rosalba Orlando Italy 7 148 1.6× 109 1.6× 80 1.4× 21 0.8× 22 1.0× 11 175
Josef Weismüller Germany 6 70 0.8× 61 0.9× 134 2.3× 69 2.7× 16 0.8× 12 230
My‐Linh Tran‐Minh France 5 116 1.3× 89 1.3× 87 1.5× 8 0.3× 14 0.7× 12 162
Simeng Lin United Kingdom 8 63 0.7× 57 0.9× 50 0.8× 38 1.5× 20 1.0× 25 168
Alicia López‐García Spain 5 165 1.8× 129 1.9× 79 1.3× 16 0.6× 40 1.9× 11 180

Countries citing papers authored by James Izanec

Since Specialization
Citations

This map shows the geographic impact of James Izanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Izanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Izanec more than expected).

Fields of papers citing papers by James Izanec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Izanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Izanec. The network helps show where James Izanec may publish in the future.

Co-authorship network of co-authors of James Izanec

This figure shows the co-authorship network connecting the top 25 collaborators of James Izanec. A scholar is included among the top collaborators of James Izanec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Izanec. James Izanec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhdanava, Maryia, Ameur M. Manceur, Zhijie Ding, et al.. (2024). Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States. Journal of Managed Care & Specialty Pharmacy. 30(2). 141–152. 3 indexed citations
2.
Colombel, Jean‐Frédéric, Bruce E. Sands, Christopher Gasink, et al.. (2023). Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 22(1). 144–153.e2. 5 indexed citations
3.
Zhdanava, Maryia, Zhijie Ding, Ameur M. Manceur, et al.. (2023). Long-term persistence and other treatment patterns among bio-naïve patients with Crohn’s disease treated with ustekinumab or adalimumab. Current Medical Research and Opinion. 39(9). 1215–1225. 4 indexed citations
4.
Panaccione, Remo, Christopher Gasink, Timothy Hoops, et al.. (2022). O30 Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials. Oral Presentations. A17–A17. 2 indexed citations
5.
Peyrin‐Biroulet, Laurent, Remo Panaccione, C Gasink, et al.. (2022). P495 Perianal fistula closure in patients receiving ustekinumab: Results from the SEAVUE and STARDUST trials. Journal of Crohn s and Colitis. 16(Supplement_1). i460–i460. 7 indexed citations
6.
Leong, Rupert W., Bruce E. Sands, Laurent Peyrin‐Biroulet, et al.. (2022). DOP55 Long-term outcomes after histologic-endoscopic mucosal healing: Results from the UNIFI study in Ulcerative Colitis. Journal of Crohn s and Colitis. 16(Supplement_1). i102–i103. 2 indexed citations
7.
Ding, Zhijie, et al.. (2022). Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States. Crohn s & Colitis 360. 4(3). otac023–otac023. 10 indexed citations
8.
Irving, Peter M., B E Sands, Timothy Hoops, et al.. (2021). OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study. Journal of Crohn s and Colitis. 15(Supplement_1). S001–S002. 18 indexed citations
9.
10.
11.
Loftus, Edward V., Silvio Danese, Remo Panaccione, et al.. (2021). S770 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: IBDQ in the SEAVUE Study. The American Journal of Gastroenterology. 116(1). S355–S357. 2 indexed citations
12.
Sands, B E, Alessandra Oortwijn, James Izanec, et al.. (2019). P317 Characterisation of patients with delayed response to ustekinumab for Crohn’s disease. Journal of Crohn s and Colitis. 13(Supplement_1). S259–S260. 4 indexed citations
13.
Hanauer, Stephen B., Bruce E. Sands, Brian G. Feagan, et al.. (2019). Tu1723 – Identification of Risk Factors Associated with Loss of Response to Ustekinumab in Crohn's Disease. Gastroenterology. 156(6). S–1099. 2 indexed citations
14.
Ding, Zhijie, et al.. (2019). 710 Relationship Between Partial Mayo Score and Patient-Reported Outcomes for Ulcerative Colitis Patients in the United States. The American Journal of Gastroenterology. 114(1). S417–S418. 1 indexed citations
15.
Danese, Silvio, Bruce E. Sands, Christopher D. O’Brien, et al.. (2019). Tu1739 – Efficacy and Safety of Ustekinumab Through Week 16 in Patients with Moderate to Severe Ulcerative Colitis Randomized to Ustekinumab: Results from the Unifi Induction Trial. Gastroenterology. 156(6). S–1106. 2 indexed citations
16.
Sands, Bruce E., Alessandra Oortwijn, James Izanec, et al.. (2019). Tu1725 – Characterization of Patients with Delayed Response to Ustekinumab for Crohn's Disease. Gastroenterology. 156(6). S–1100.
17.
Ding, Zhijie, et al.. (2019). 763 Relationship Between Crohn's Disease Activity Index and Patient-Reported Outcomes for Crohn's Disease Patients in the United States. The American Journal of Gastroenterology. 114(1). S444–S445. 1 indexed citations
18.
Izanec, James & Deborah Nagle. (2006). Impact of Proctectomy on Continence and Sexual Function in Women. The American Journal of Gastroenterology. 101(s3). S618–S624. 9 indexed citations
19.
Izanec, James & Deborah Nagle. (2006). Impact of Proctectomy on Continence and Sexual Function in Women. The American Journal of Gastroenterology. 101. S618–S624. 1 indexed citations
20.
Izanec, James, et al.. (2004). Achalasia Presenting After Operative and Nonoperative Trauma. Digestive Diseases and Sciences. 49(11-12). 1818–1821. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Forss Breakdown of academic impact, for papers by Laurent Peyrin-Biroulet Breakdown of academic impact, for papers by Cyrielle Gilletta Breakdown of academic impact, for papers by Daniel Hervías Breakdown of academic impact, for papers by Luca Ferraris Breakdown of academic impact, for papers by Rosalba Orlando Breakdown of academic impact, for papers by Josef Weismüller Breakdown of academic impact, for papers by My‐Linh Tran‐Minh Breakdown of academic impact, for papers by Simeng Lin Breakdown of academic impact, for papers by Alicia López‐García
Rankless by CCL
2026